Yingxu Shi
- Topics
- MicroRNA in disease regulation (4 papers)RNA modifications and cancer (3 papers)Circular RNAs in diseases (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Yingxu Shi
19 papers receiving 386 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 250
- Cancer Research 137
- Oncology 43
- Plant Science 41
- Immunology 39
Countries citing papers authored by Yingxu Shi
This map shows the geographic impact of Yingxu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingxu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingxu Shi more than expected).
Fields of papers citing papers by Yingxu Shi
This network shows the impact of papers produced by Yingxu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingxu Shi. The network helps show where Yingxu Shi may publish in the future.
Co-authorship network of co-authors of Yingxu Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Yingxu Shi. A scholar is included among the top collaborators of Yingxu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingxu Shi. Yingxu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 7 | |
| 5 | 5 | |
| 6 | 5 | |
| 7 | 3 | |
| 8 | 7 | |
| 9 | 1 | |
| 10 | 12 | |
| 11 | 1 | |
| 12 | 12 | |
| 13 | Histopathologic characteristics and immunotypes of perivascular epithelioid cell tumors (PEComa). | 16 |
| 14 | 53 | |
| 15 | 33 | |
| 16 | 35 | |
| 17 | 19 | |
| 18 | [Expression of ADAR1 isoforms in murine acute T-ALL leukemia model]. | 2 |
| 19 | 173 | |
| 20 | [Study on the relationship between two second-messenger pathways on the regulation of proliferation and differentiation in MGc 80-3 cells]. | 2 |
About Yingxu Shi
Yingxu Shi is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 20 papers that have together received 389 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (137 citations), Molecular Biology (250 citations) and Orthopedics and Sports Medicine (17 citations). Yingxu Shi has collaborated with scholars based in China and United States. Frequent co-authors include Hong Jiang, Hanjiang Fu, Chengwang Xu, Xiaofei Zheng, Jie Zhu, Yi Tie, Zhixian Sun, Zhuoyuan Zhang, Xiulan Su and Bo Yang. Their work appears in journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.